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The collagen VII gene, COL7Al, is the candidate gene for 
both the recessive and dominant forms of dystrophic epider-
molysis bullosa (EBD). Collagen VII is a structural protein of 
the anchoring fibrils, which are rudimentary or altered in 
several subtypes ofEBD. In severe recessive mutilating EBD, 
anchoring fibrils and collagen VII are not detectable in skin 
of most patients. To elucidate the underlying pathogenetic 
mechanisms, we analyzed collagen VII expression in cutane-
ous cells of six patients with this severe EBD subtype. Nei-
ther keratinocytes nor fibroblasts synthesized detectable 
amounts of collagen VII protein; however, Northern blot 
D ystrophic epidermolysis bullosa (EBD) represents a heterogeneous group of heritable skin disorders characterized by blistering and scarring of the skin after minor trauma [1-3]. Tissue separation occurs below the dermal-epidermal basement membrane, 
at the level of the anchoring fibrils that attach the epidermis to the 
papillary dermis. Ultrastructural investigations have suggested in-
volvement of these fibrils in the pathogenesis of EBD [1-3], and 
immunochemical studies demonstrated absence or drastically re-
duced levels of collagen VII, the main component of the fibrils, in 
skin and keratinocytes in severe mutilating EBD [4,5]. In line with 
these observations, genetic linkage has been established between the 
collagen VII gene and the mutilating form ofEBD [6], and a recent 
study disclosed the first homozygous point mutation resulting in 
Met to Lys substitution in the NC-2 domain of collagen VII in two 
siblings with a relatively mild form of recessive EBD [7]. 
Collagen VII is a homotrimeric molecule consisting of three 
identical a1 (VII) chains [8]. Each chain contains a central repetitive 
-Gly-X-Y- amino acid sequence of about 145 kilodaltons (kD), a 
large globular N-terminus (NC-1) of about 145 kD, and a small 
globular C-terminus (NC-2) ofless than 30 kD [9 -11]. Two colla-
gen VII molecules assemble into an antiparall.el tail-to-tail dimer 
with a small carboxy-terminal overlap and with the amino-termini 
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analysis revealed small amounts of normal-size collagen VII 
mRNA in both EBD and control fibroblasts. When 
the mRNA was amplified using reverse transcription_ 
polymerase chain reaction, correct amplimers were present in 
all specimens. The results demonstrate that transcription of 
the COL7 Al gene occurs in these patients with severe muti-
lating EBD and suggest that post-transcriptional or post-
translational events lead to absence of collagen VII protein 
from skin. Key words: anchoring fibrils/basement mem-
brane /blistering disorders/dermal-epidermal junction/ poly-
merase chain reaction. ] Invest Dermatol1 02:260-262, 1994 
pointing outwards. Several dimers aggregate laterally in a non-stag_ 
gered manner to form the anchoring fibrils [8] . 
To elucidate the molecular mechanisms underlying lack of colla-
gen VII and the anchoring fibrils in mutilating EBD, we analyzed 
collagen VII expression at the protein and mRN A level in cutaneous 
cells of six patients who lacked this collagen in the skin. 
MATERIALS AND METHODS 
Biopsies and Cell Cultures The patients included six individuals origi-
nating from different European coumries. All belonged to non-consan_ 
guineous families, with no other family members affected. All suffered from 
trauma-induced blistering of the skin and mucous membranes since birth 
and severe course of the disease led to extensive scarring and to digital fusio~ 
with advancing age. Biopsies from clinically uninvolved skin were used for 
immunomapping and for initiation of cell cultures as described [5). 
Antibodies and Immunofluorescence (IF) Staining Polyclonal anti-
bodies to the triple-helical domain of human collagen VII were affinity 
purified as described [12) . The monoclonal antibody LH-7.2 [13) recogniz_ 
ing an epitope in the globular aminoterminal domain of collagen VII Was 
purchased from Chernicon International, Inc. (Temecula, CA). IF staining 
of cryosections of skin or subconfluent cells on covers lips was carried out as 
described [5). 
Analysis of Collagen VII mRNA Poly A-RNA was separated on a 1 % 
agarose gel containing 2.2 M formaldehyde and transferred onto a Nytran 
nylon filter (Schleicher & Schuell, Dassel, Germany). The filters were pre-
hybridized and hybridized in the presence of 50% formamide and 7% SDS 
[14) with the 1.9-kilobase pair (kb) collagen VII eDNA K131 [15) and a 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) eDNA. Single-
stranded eDNA was reverse transcribed from mRNA and used as template 
for polymerase chain reaction (PCR) amplification [16). The primer design 
was based on collagen VII cDNA sequences to generate 11 overlapping 
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Table I. Probands in the Present Study 
Immunomapping of the Skin 
Age Country Clinical 
Patient (years) of Origin Course Collagen IV Collagen VII 
I 20 Finland Severe Blister roof Negative 
II 4 Switzerland Severe Blister roof Negative 
III 1 Yugoslavia Severe Bl is ter roo f Faint 
IV 2 Italy Severe Blister roof Negative 
V 5 Sweden Severe Blister roof Negative 
VI 1/12 Turkey Severe Blister roof Negative 
r ers corresponding to the NC-l domain [9,10,14] and four overlap-
amp l;'plimers correspond.ing to the NC-2 domain [11]. The amplimers 
pmg nalyzed in non-denaturing acrylamide gels (MDE-Gels, J.T. Baker 
were a I ' I d dr' I I Phillipsburg, NJ) using t 1e PCR-smg e-stran e conrormatlOn po y-~~;phisms (SSCP) technique [17]. 
RESULTS 
EBD Cells Do Not Synth~size Detec~able Amounts ,!f C~lla­
gen vn Protein IF stallnln
l 
g of the sb~ wfilth bot~l anti bOd ies to 
collagen VII was com~ ete y ne~atlve In . ve patients an . v~ry 
faintly positive In the bhster roof 111 one patient (Table I). Sta1l11I~g 
of the cells revealed a positive intrac~llular granular fluores~ence In 
control keratinocytes, ~ut .no reactIOn 111 the E~D kerat1l10cytes 
from two patients, indlcat1l1g that these cells did not syntheSize 
normal amounts of this collagen. Fibroblasts.express c~lla~en VII at 
a very low level, and in normal cells.a very fa111tly poslt1~e Immuno-
fluorescence signal was detected With collagen VII antibodies, but 
EBD fibroblasts of all patients remained negative. 
EBD Fibroblasts Express Collagen VII mRNA PolyA-RNA 
was isolated from keratinocytes of two EBD patients and fr?l~ fi-
broblasts of all patients, as well as from control cells, and hybndlzed 
with radiolabeled collagen VII cDNA. All samples revealed a sin~le 
mRNA of 9 kb in size (Fig 1). The relative quantity of speCific 
collagen VII mRNA present in the EBD fibroblasts was similar to 
that in normal fibroblasts and remarkably less than that recov~red 
from normal keratinocytes. Because the collagen VII mRNA IS of 
low abundance in fibroblasts, large amounts were used to obta1l1 
detectable signals. Therefore, the resulting bands were broad an.d 
somewhat diffuse. The size of the mRNA could be roughly esti-
mated, but it would not be possible to d.istinguish small differences 
in migration positions of the mRNAs !-n these b~ots . TI~erefore , a 
reverse transcript (RT)-PCR analYSIS ot the functIOnally Important 
NC-1 and NC-2 domains [9-11) of collagen VII was performed. 
RT-PCR with mRNAs from control and EBD fibroblasts yielded 
products of the expected size in all specimens, and all amplimers 
showed normal mobility on SSCP gels. 
DISCUSSION 
Here we demonstrate that a group of patients with severe mutilating 
EBD lack collagen VII from the skin and cutaneous cells: despite the 
fact that the cells express collagen VII mRNA. Both kerat1l10cytes and 
fibroblasts synthesized mRNA of normal size, although the levels in 
fibroblasts were remarkably lower than in the epidermal cells. 
A similar situation with lack of a protein product but expression 
of mRNA has been observed in other heritable collagen disorders, 
such as the Ehlers-Danlos syndrome type IV [18). Analogously, 
collagen VII mutations may be present in this group of EBD mu~i­
lans patients. Point mutations have been most commonly fo~nd 111 
heritable collagen disorders and are therefore hkely to occur 111 the 
COL7 A 1 gene as well. In the present group of patients, a mutation 
introducing a premature stop cod~n in the mRNA fo~ the a: (VII) 
chain would interrupt the translatIOn of the polypeptide cham, and 
residual small aminoterminal fragments, as long as they escape in-
tracellular degradation, might not be detected with the antibodies 
used. Yet, presumably at least some mRNA would remain intact and 
be visible in Northern blots. In this context, it is of interest that 
premature stop codons induced by insertions, deletions, or point 
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Figure 1. Northern blotting of collagen VII mRNA with radiolabeled 
cDNA K131 (upper pallel) and GAPDH cDNA (lolVer palle/). mRNA was 
isolated from normal fibroblasts (la"e 1), normal keratinocytes (lalle 2), and 
fibroblasts from patients I - VI (lall es 3 - 8) . Note the presence of the collagen 
VII mRNA (9 kb) in all lalles. 
mutations in the COL7 A1 gene have been detected insome patients 
with recessive EBD~ (Christiano et ai, personal communication). 
Alternatively, any mutation causing elimination of the repetitive 
-Gly-X-Y - sequence that is a prerequisite for a stable collagen triple 
helix renders the molecule sensitive to physiologic degradation. 
We have analyzed the cDNAs derived from the present EBD 
fibrob last mRNAs using the PCR-SSCP technique. A number of 
primers covering the entire NC-1 and NC-2 domain have been 
employed for these analyses. No aberrantly moving amplimers were 
observed with SSCP electrophoresis, demonstrating that the func-
tionally important globular domains of collagen VII are normal in 
these patients, and that the putative mutations lie in the gene seg-
ment coding for the triple helical domain. 
The probands included in the present study belong to families 
with no other affected members. Therefore, the mode of inheri-
tance cannot be determined at the present time. However, EBD 
with a severe mutilating phenotype is generally regarded as a reces-
sive disease, and it is likely that at least some of the patients are 
homozygous for the same mutation or compound heterozygotes 
with different mutations in each allele. It is reasonable to expect 
that, again in analogy with other collagen disorders, different muta-
tions may be revealed in each EBD family, in spite of the fact that all 
the probands examined here present with a rather similar clinical 
phenotype and with the fluorescence microscopic finding of absent 
collagen VII in the skin. 
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Further information can be obtained from The Secretariat, 11 th Regional Conference of 
Dermatology, c/o Conference & Exhibition Management Services P/L, 1 Maritime Squm:e 
#09-43, World Trade Centre, Singapore 0409. Tel, 2788 666; Fax, 2784 077. Attn: Maggie 
Phang. 
